Study Status: Not yet recruiting
Recruit Status: Not yet recruiting
Study Type: Interventional
Official Title: A Phase 2 Study of Abemaciclib for Patients With Retinoblastoma-Positive, Triple Negative Metastatic Breast Cancer
Brief Summary: This research study is studying a drug called Abemaciclib as a possible treatment for have metastatic triple-negative type of breast cancer.